A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.

New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem ...

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Scientists sometimes compare predicting the course of epidemics to forecasting the weather. But there's a major ...

A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the "macrodomain," found in all coronaviruses such as SARS-CoV-2 and ...

South Korea–based biotech firm LUCA AICELL has developed LUCA V-Defense Nasal Spray, a drug-free nasal spray designed to form a protective barrier on the nasal lining—offering a modern solution in the ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

Scientists have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19.

Scientists at La Jolla Institute for Immunology (LJI) have developed six lines of humanized mice that can serve as valuable models for studying human cases of COVID-19.

For our Spotlight on patient-derived in vitro cell models, we surveyed our audience to find out the latest trends, opinions and behaviors in the field. This infographic summarizes the results from the ...

In a new study, researchers developed a three-dimensional (3D) in vitro tissue model to assess the effects of SARS-CoV-2 on the vascular endothelial cells.